Compremium

Focus: Compremium is a Swiss diagnostic company focused on non-invasive measurement tools for vascular and compartment health assessment. The company operates as a pre-revenue or early-stage medical device developer with limited public disclosure of scale.

Vascular Health

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Total Funding

$35M

Open Jobs

About Compremium

AI assessmentNot Hiring

No open roles listed right now. Follow Compremium to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Measurement of compartment compressibility using the CPMX1 device

Compartment Syndromes

N/A

Clinical Trials (1)

NCT06030635ACS Monitoring Charité Berlin

N/A

Help build intelligence for Compremium

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity in an emerging diagnostics platform with applications across multiple clinical areas (liver cirrhosis, compartment syndromes, cardiac ICU, intracranial pressure)
Swiss headquarters provides access to strong medical device ecosystem and regulatory expertise
Early-stage company offers broader skill exposure and faster advancement potential than established organizations

Watch Out For

Extreme data scarcity: no funding disclosed, no employee count, founding date, or financial statements—raises questions about company viability and transparency
Pipeline programs show no traditional clinical phase designation (all marked 'N/A'), suggesting device is in early validation or pre-clinical stages with unclear regulatory pathway
Only 1 active job opening despite multi-program pipeline indicates minimal hiring momentum and potential capital constraints

Generated by Claude from Compremium's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Measurement of compartment compressibility

Compartment Syndromes

N/A

Clinical Trials (1)

NCT05483946SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1

N/A

CPMX3

Intracranial Pressure

N/A

Clinical Trials (2)

NCT07550361Validation of Non-Invasive Intracranial Pressure Estimation Using CPMX3 in the Periorbital Vein: A Feasibility Study in Pediatric Patients

N/A

NCT07222826Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein

N/A

CPMX2

Cardiac Intensive Care

N/A

Clinical Trials (1)

NCT07226479Non-invasive Venous Pressure Estimation

N/A

CPMX2

Central Venous Pressure

N/A

Clinical Trials (1)

NCT06885073Non-invasive Central Venous Pressure Estimation in Pediatric Patients

N/A

Measurement of compartment compressibility

Compartment Syndromes

N/A

Clinical Trials (1)

NCT05367921SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1

N/A

CPMX2

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT06544161EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin Substitution

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 8 clinical trials

Top TAs: Gastroenterology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Gastroenterology

1 pipeline

Marketed

Pipeline